Public Company News

Youdao Reports Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results

HANGZHOU, China, Feb. 24, 2022 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), a leading intelligent learning company inChina, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2021. Fourth Quarter 2021 Financial Highli...

2022-02-24 17:09 3937

NetEase Reports Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results

HANGZHOU, China, Feb. 24, 2022 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), one ofChina's leading internet and online game services providers, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2021....

2022-02-24 16:30 4390

Electrolux publishes 2021 Annual Report

STOCKHOLM, Feb. 24, 2022 /PRNewswire/ -- The Annual Report in Swedish as well as an English translation are available onwww.electroluxgroup.com in pdf-format and will be distributed inmid-March 2022 to shareholders who have requested it. The Swedish Annual Report is also available on the Group's ...

2022-02-24 16:25 2845

MPC Container Ships ASA reports Q4 and twelve-month 2021 results

-   Significantly improved operating revenues of USD 142.5 million and EBITDA of USD 162.7 million, up by 20% and 121%, respectively, compared to Q3 2021. -   Quarterly dividend of USD 0.11 per share (around USD 50m) declared for Q4 2021. -   Projected EBITDA backlog now in excess of USD 1.1 bill...

2022-02-24 16:06 2323

Hyundai, Kia and Genesis Sweep 2022 IIHS TOP SAFETY PICK+ and TOP SAFETY PICK Awards

* Insurance Institute for Highway Safety (IIHS) recognizes Hyundai Motor Group as the industry leader in safety, having bestowed the organization with the greatest combined number of 2022 awards * Hyundai Motor, Kia and Genesis take 21 TOP SAFETY PICK+ (TSP+) and TOP SAFETY PICK (TSP) awards ...

2022-02-24 16:00 4099

ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS

Full Year 2021 Highlights (as compared to the Full Year 2020): * Record Full Year Revenue and Net Earnings * 19% Increase in Revenue to US$987.7 Million from US$829.5 Million * 44% Expansion of Gross Profit to US$261.5 Million from US$181.4 Million * 460 Basis Point Improvement in Gross Mar...

2022-02-24 14:20 3563

Q4 & FY21 Results

Revenue momentum accelerates, margins strong AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange ZURICH, Feb. 24, 2022 /PRNewswire/ -- Q4 HIGHLIGHTS * Revenues +3% sequentially, +1% yoy organic TDA1, led by Modis +14% * Gross profit +7% organic yoy; led by Adecco +7% ...

2022-02-24 13:47 5266

Primary endpoint met in Phase III clinical trial of Trilaciclib in Chinese patients with small cell lung cancer

HONG KONG, Feb. 24, 2022 /PRNewswire/ -- On February 23 2022, Simcere Pharmaceutical Group (2096.HK) announced that the phase III clinical registration study of Trilaciclib in patients with extensive-stage small cell lung cancer (ES-SCLC) has met its primary endpoint. The drug co-developed in Chi...

2022-02-24 13:34 2260

Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China

BEIJING, SHANGHAI and BOSTON, Feb. 23, 2022 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) announced that its KRAS G12C inhibitor JAB-21822 completed the first patient dosing in combinationtherapy with Cetuximab at Peking University Cancer Hospital recently. JAB-21822 in combination with ce...

2022-02-24 10:32 2216

Alphamab Oncology Announced Publication of Clinical Results of KN026 in HER2-positive Breast Cancer in Clinical Cancer Research

SUZHOU, China, Feb. 24, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announcedClinical Cancer Research, a journal of the American Association for Cancer Research (AACR), published the data from a phase I clinical study of the company's proprietary HER2 bispecific antibody KN026 fo...

2022-02-24 09:41 3350

IMAX CHINA REPORTS FULL-YEAR 2021 FINANCIAL RESULTS

GREATER CHINA HIGHLIGHTS (Note: Percentage and other changes refer to full-year 2020 unless otherwise noted) * IMAX China delivered a strong revenue rebound to US$113 million for the full-year of 2021, up 116% year-on-year, driven by recovery in box office and installation activities. * Tech...

2022-02-24 09:23 5857

Innovent Announces First Patient Dosed with CD73 Antibody in Phase 1a/1b Clinical Trial for Advanced Solid Tumor

SAN FRANCISCO and SUZHOU, China, Feb. 24, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2022-02-24 08:00 4402

DISCOVERY SEES RECORD WINTER OLYMPICS WITH DISCOVERY+ LEADING THE WAY

* New paid streaming subscribers for Beijing 2022 exceed PyeongChang 2018 by almost 50% * Over 1 billion streaming minutes consumed across discovery+ and Eurosport subscription services * Discovery's average linear TV audiences, both free-to-air and Eurosport, remain resilient and in line w...

2022-02-24 06:23 2759

Nisun Clarifies the Cooperation with ADM (Shanghai) Management

SHANGHAI, Feb 23, 2022 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd ("Nisun" or the "Company") (Nasdaq: NISN), a provider of innovative comprehensive solutions through an integration of technology, industry, and finance, today clarified and corrected itsJanuary 14, 2...

2022-02-24 05:05 2403

Foresee Pharmaceuticals and TRPharm Announce License and Co-Development Agreement

TAIPEI, Feb. 23, 2022 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), aTaiwan and US-based biopharmaceutical company and TRPharm, a leading Turkish healthcare company, announced today that they have entered into an exclusive license agreement for the co-development and ...

2022-02-23 23:00 2897

Hyundai Mobis Enhances Shareholder Value by Securing Sustainable Growth

SEOUL, South Korea, Feb. 23, 2022 /PRNewswire/ -- Hyundai Mobis expressed its willingness once more to enhance shareholder returns based on mid to long-term growth after its previous 3-year policy. In the '2022 Shareholder Value Maximization Policy' the company recently released, Hyundai Mobis an...

2022-02-23 22:00 2720

Luokung Affiliate eMapgo Provides Mapping Services for Ford Smart Vehicles

BEIJING, Feb. 23, 2022 /PRNewswire/ -- Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company"), a leading spatial-temporal intelligent big data services company and provider of interactive location-based services ("LBS") and high-definition maps ("HD Maps") inChina, today announced t...

2022-02-23 22:00 2806

Sands Gallery Opens at The Grand Suites at Four Seasons

MACAO, Feb. 23, 2022 /PRNewswire/ -- Sands China Ltd. officially launched the newSands Gallery Wednesday and unveiled its debut exhibition, The Innovation of Ink: Transformation and Reinvention of Oriental Aesthetics – Featured Exhibition of Wang Dongling &Xu Lei.

2022-02-23 21:44 5283

Jiuzi Holdings, Inc. Signs Strategic Cooperation Agreement with Leading Electric Vehicle Manufacturer in China

HANGZHOU, China, Feb. 23, 2022 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN; the "Company"), a new energy vehicles franchisor and retailer under the brand name "Jiuzi" inChina, today announced that, on January 6, 2021, the Company, through its wholly-owned subsidiary, Zhejiang Jiuzi New Ene...

2022-02-23 21:00 2032

Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results

HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release its financial result...

2022-02-23 20:00 2821

Week's Top Stories